Navigation Links
NicOx Completes Enrollment in Second Pivotal Phase 3 Study for Naproxcinod and Provides Development Update
Date:12/14/2007

SOPHIA ANTIPOLIS, France, Dec. 14 /PRNewswire-FirstCall/ -- NicOx S.A. (Eurolist: COX) today announced it has successfully completed the enrollment of 1020 patients in the 302 pivotal phase 3 study for naproxcinod, in-line with projections. Naproxcinod is the Company's lead investigational drug product and the first compound in the COX-Inhibiting Nitric Oxide-Donating (CINOD) class. The 302 study is designed to assess naproxcinod's efficacy for treating the signs and symptoms of osteoarthritis and provide additional blood pressure data, which is a key factor for differentiating naproxcinod from existing anti-inflammatory treatments. Efficacy results from this study are anticipated in the third quarter of 2008.

The 302 study represents the largest of the three pivotal phase 3 trials for naproxcinod (the 301, 302 and 303 studies). The 301 study is complete and results were recently presented at the 71st annual meeting of the American College of Rheumatology (ACR), which showed that naproxcinod met all three co-primary efficacy endpoints and demonstrated a similar effect on systolic blood pressure to placebo and a reduction compared to naproxen, a commonly used anti-inflammatory agent. The third and final study (303) is a 13-week trial in patients with osteoarthritis of the hip. Patient enrollment in this trial is well underway, following its initiation in June 2007. Current timelines are that the 303 study should complete enrollment in the second quarter of 2008, with results expected by the end of 2008. NicOx now anticipates the filing of a New Drug Application (NDA) for naproxcinod with the US Food and Drug Administration (FDA) in mid-2009.

"The 302 study is the largest and longest duration trial in our program for naproxcinod and our clinical team has proved its effectiveness in successfully recruiting the targeted number of patients in-line with projected timelines," said Pascal Pfister, Chief Scientific Officer of NicOx. "The 302 study will p
'/>"/>

SOURCE NicOx S.A.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
2. NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology
3. NicOx Naproxcinod ABPM Data Presented at American Heart Association
4. NicOx Naproxcinod Phase 3 Results Presented at American College of Rheumatology
5. NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
11. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2015)... 2015  AbbVie (NYSE: ABBV ) has announced ... accepted its New Drug Application (NDA) and granted priority ... treatment of ombitasvir, paritaprevir, ritonavir (OBV/PTV/r), with ribavirin (RBV). ... chronic genotype 4 (GT4) hepatitis C virus (HCV) infection. ... therapy being evaluated by the FDA for patients in ...
(Date:4/23/2015)... April 23, 2015 /CNW/ - Health Canada is working ... to update the safety information regarding the risk of ... when these products are used at high doses (at ... and duration of use. Ibuprofen is a ... relief, and to reduce inflammation. The majority of ibuprofen ...
(Date:4/23/2015)... Surna, Inc. (OTCQB: SRNA), a technology company ... and systems for controlled environment agriculture ("CEA") with ... host a shareholder conference call to discuss its ... PM Eastern Standard Time/1:15 PM Pacific Standard Time. ... listen-in only, but will include a Q&A session ...
Breaking Medicine Technology:U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 2Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 3Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 4Surna, Inc. Announces Shareholder Conference Call 2Surna, Inc. Announces Shareholder Conference Call 3
... BEIJING , July 15 /PRNewswire-Asia/ -- Sinovac Biotech ... China , announced today that it,held its 2010 Annual Meeting of ... Beijing Time. The required quorum, a majority of the ... was held,concurrently at No. 39 Shangdi Xi Road, Haidian District, ...
... SUNNYVALE, Calif. , July 15 Premier ... and 67,000-plus other healthcare sites working together to achieve ... provider of FDA-cleared Electronic Brachytherapy Systems, announced the execution ... exclusive three-year contract for brachytherapy systems with Premier Purchasing ...
Cached Medicine Technology:Sinovac Holds 2010 Annual Meeting of Shareholders 2Xoft Announces Exclusive Contract With Premier for Electronic Brachytherapy 2Xoft Announces Exclusive Contract With Premier for Electronic Brachytherapy 3
(Date:4/26/2015)... NC (PRWEB) April 26, 2015 Italian ... the deadly legacy of asbestos cement plants and other ... on the new research. Click here to read ... from Italy’s Department of Occupational and Environmental Medicine analyzed ... 2008 and found 32 clusters where the asbestos cancer ...
(Date:4/26/2015)... Indianapolis, Indiana (PRWEB) April 26, 2015 ... network service provider announces that Brotherhood Mutual Insurance Company ... Daniel Armstrong, Manager of Network Infrastructure at Brotherhood Mutual ... value and the service reliability Brotherhood Mutual needed. ... route diversity, and IFN worked with us to ensure ...
(Date:4/26/2015)... NV (PRWEB) April 26, 2015 From ... Trivedi and his wife, Trivedi Master™ Dahryn Trivedi, spent ... FDA approved research laboratories and institutions in the efforts ... drugs, medicine and nutraceutical supplements for human health care. ... 12 different research labs and institutions. All lab facilities ...
(Date:4/26/2015)... (PRWEB) April 26, 2015 India Network ... in delivering valuable community services to the Asian Indian ... projects in India for more than two decades. The ... and thousands of subscribers around the world with the ... at that time. The Immigration Law Forum Digest, edited ...
(Date:4/26/2015)... Santa Rosa, CA (PRWEB) April 26, 2015 ... researchers from Washington State University evaluated the head-neck biomechanics occurring ... Authors of the study were able to determine that use ... as much as 3 to 5 times - more than ... a surprising outcome for such a study, but pointing out ...
Breaking Medicine News(10 mins):Health News:New Investigation Finds Mesothelioma “Clusters” Around Italian Cement Plants, According to Surviving Mesothelioma 2Health News:Brotherhood Mutual Insurance Company Selects Indiana Fiber Network, LLC for Fiber Transport Service 2Health News:Brotherhood Mutual Insurance Company Selects Indiana Fiber Network, LLC for Fiber Transport Service 3Health News:Trivedi Science™ Has Started Scientific Research to Create More Effective Pharmaceuticals and Nutraceuticals 2Health News:Trivedi Science™ Has Started Scientific Research to Create More Effective Pharmaceuticals and Nutraceuticals 3Health News:North American Telugu Society Bestows Community Service Award to India Network Foundation for Its Generosity and Sponsor of Visitor Health Insurance to Indian Visitors 2Health News:North American Telugu Society Bestows Community Service Award to India Network Foundation for Its Generosity and Sponsor of Visitor Health Insurance to Indian Visitors 3Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 2Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 3Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 4
... peers, are key, study finds , , THURSDAY, April 16 ... most important relationships. , But new research shows its ... prevent suicidal behavior in teens who,ve experienced depression or ... high school and a previous suicide attempt were significant ...
... The "Help is Here Express" bus tour will ... - April 24 at various cities in order to help ... prescription medicines for free or nearly free. With the state,s ... of 8.5 percent, the Partnership for Prescription Assistance (PPA) is ...
... the highlights of the annual meeting of the American ... TV quiz shows. , Like a quiz show, Neurobowl ... subtracts points for wrong answers. The tougher the question, ... to diagnose perplexing neurological conditions, based on symptoms, video ...
... To provide greater public access to discussions and deliberations involving ... Americans , the Department of Agriculture today announced that the ... be web-streamed live on April 29th and 30th.A notice regarding ... Federal Register . The Committee will meet on ...
... to expand relationship with healthcare technology solutions providerPLANO, ... and Perot Systems Corporation (NYSE: PER ... an agreement in which Perot Systems will provide ... The multi-year agreement continues TCH,s current relationship where ...
... Nationwide Foundation is making a $1.7 million grant ... affected by disasters and other life-threatening emergencies. This ... contributed this unique grant to the Red Cross.(Logo: ... Nationwide Foundation, an independent corporation funded by Nationwide ...
Cached Medicine News:Health News:Family Ties May Help Prevent Teen Suicide 2Health News:Partnership for Prescription Assistance Prepared to Help Indiana Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help Indiana Workers Hurt by Recession 3Health News:What do neurologists do for entertainment? 2Health News:2010 Dietary Guidelines Advisory Committee Meeting to Be Webcast April 29th and 30th 2Health News:The Christ Hospital Selects Perot Systems for Revenue Cycle Solutions 2Health News:The Christ Hospital Selects Perot Systems for Revenue Cycle Solutions 3Health News:Nationwide Foundation Donates $1.7 Million to American Red Cross for Disaster Preparedness and Response and Increased Blood Collections 2Health News:Nationwide Foundation Donates $1.7 Million to American Red Cross for Disaster Preparedness and Response and Increased Blood Collections 3Health News:Nationwide Foundation Donates $1.7 Million to American Red Cross for Disaster Preparedness and Response and Increased Blood Collections 4
Comprehensive range of integrated implants and instruments including - Basic, Small, Mini, Pelvic and Foot Sets....
... international engineering and design specifications, Smith ... System* provides seamless integration with existing ... open reduction internal fixational procedures (AO ... well beyond the standard, providing a ...
... has been developed for the transvenous closure ... venous sheaths the device offers a safe ... of ASD's with a super low profile.,A ... twelve arm device for optimal positioning and ...
Stainless steel threaded Steinman Pins available in point types A,D, E, and F....
Medicine Products: